Middle East & Africa Infusion Devices Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The Middle East and Africa infusion devices market is projected to grow from US$ 457.09 million in 2023 to US$ 720.81 million by 2031, reflecting a compound annual growth rate (CAGR) of 5.9% during this period.

Executive Summary and Market Analysis

This market encompasses key regions including Saudi Arabia, the UAE, South Africa, and the broader Middle East and Africa. The anticipated growth is driven by rising incidences of chronic conditions such as diabetes and cancer, alongside an aging population that necessitates increased medical care. Notably, the UAE is expected to emerge as the fastest-growing market due to its expanding medical tourism sector.

Market Segmentation

The infusion devices market is categorized based on product type, application, and end user:

1. Product Type: The market is divided into infusion pumps and infusion sets, with infusion pumps dominating the market share in 2023. Within infusion pumps, volumetric pumps, syringe pumps, insulin pumps, patient-controlled analgesia (PCA) pumps, enteral pumps, implantable pumps, and elastomeric pumps are included. Volumetric pumps held the largest market share in this category. Infusion sets are further classified into vented and non-vented sets, with vented sets leading in market share.

2. Application: The market is segmented into diabetes, oncology, pain management, hematology, pediatrics, gastroenterology, and others. Diabetes applications accounted for the largest share in 2023.

3. End User: The end users include hospitals and specialty clinics, homecare settings, ambulatory surgical centers, and others, with hospitals and specialty clinics holding the largest market share.

Market Outlook

The healthcare sector is witnessing rapid technological advancements, particularly in IV infusion systems. Innovations such as smart pumps, wireless connectivity, and electronic health record (EHR) integration are enhancing operational efficiency and patient safety. For instance, Baxter's Novum IQ Large Volume Infusion Pump, which received FDA clearance in April 2024, exemplifies the trend towards connected infusion therapy, offering smart pumps that ensure accurate dosing and improve clinician efficiency.

Remote monitoring capabilities are also transforming infusion therapy management, allowing healthcare providers to oversee multiple infusion setups from a centralized location. Infuzamed's mobile, wearable infusion pump is a notable example, providing advanced remote monitoring without the encumbrance of traditional equipment.

The integration of infusion systems with electronic health records streamlines documentation and enhances data accessibility, which is crucial for operational efficiency. WellSpan Health's implementation of the Alaris System across its hospitals illustrates this trend, enabling bidirectional interoperability between infusion devices and EHRs.

User interface improvements are also critical, as intuitive designs reduce the likelihood of errors during administration. B. Braun's infusion pumps, which share a common user interface and drug library, highlight the focus on enhancing user experience.

Country Insights

The market analysis reveals that Saudi Arabia held the largest share in 2023. The healthcare landscape in Saudi Arabia is evolving, driven by technological advancements and a growing emphasis on research and development. The demographic shift towards an aging population is increasing the demand for healthcare services, particularly for chronic diseases like diabetes and cardiovascular conditions. According to the International Diabetes Federation, approximately 4.27 million adults in Saudi Arabia were diagnosed with diabetes in 2021, indicating a prevalence rate of 17.7%. This trend underscores the need for effective infusion therapies that minimize adverse effects.

Company Profiles

Key players in the Middle East and Africa infusion devices market include B Braun SE, Baxter International Inc, Becton Dickinson and Co, BPL Medical Technologies Pvt Ltd, CODAN US Corp, Eitan Medical Ltd, Elimedical Inc, Fresenius Kabi AG, ICU Medical Inc, KD Scientific Inc, Medtronic Plc, Moog Inc, Nipro Corp, Polymedicure, Tandem Diabetes Care Inc, Terumo Corp, and Zimed Healthcare Ltd. These companies are pursuing strategies such as market expansion, product innovation, and mergers and acquisitions to enhance their offerings and increase market share.

In summary, the Middle East and Africa infusion devices market is poised for significant growth, driven by technological advancements and increasing healthcare demands.

Product Code: BMIRE00032021

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. Middle East & Africa Infusion Devices Market Landscape

4.1 PEST Analysis

5. Middle East & Africa Infusion Devices Market - Key Market Dynamics

5.1 Middle East & Africa Infusion Devices Market - Key Market Dynamics
5.2 Market Drivers
- 5.2.1 Increasing Prevalence of Cancer
- 5.2.2 Growing Geriatric Population
5.3 Market Restraints
- 5.3.1 Frequent Product Recalls of Infusion Devices
5.4 Market Opportunities
- 5.4.1 Strategic Initiatives by Market Players
5.5 Future Trends
- 5.5.1 Growing Technological Advancements
5.6 Impact of Drivers and Restraints:

6. Middle East & Africa Infusion Devices Market - Analysis

6.1 Middle East & Africa Infusion Devices Market Revenue (US$ Million), 2021-2031
6.2 Middle East & Africa Infusion Devices Market Forecast Analysis

7. Middle East & Africa Infusion Devices Market Analysis - by Product Type

7.1 Infusion Pumps
- 7.1.1 Overview
- 7.1.2 Infusion Pumps: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Infusion Sets
- 7.2.1 Overview
- 7.2.2 Infusion Sets: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. Middle East & Africa Infusion Devices Market Analysis - by Application

8.1 Diabetes
- 8.1.1 Overview
- 8.1.2 Diabetes: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Oncology
- 8.2.1 Overview
- 8.2.2 Oncology: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Pain Management
- 8.3.1 Overview
- 8.3.2 Pain Management: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.4 Hematology
- 8.4.1 Overview
- 8.4.2 Hematology: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.5 Pediatrics
- 8.5.1 Overview
- 8.5.2 Pediatrics: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.6 Gastroenterology
- 8.6.1 Overview
- 8.6.2 Gastroenterology: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.7 Others
- 8.7.1 Overview
- 8.7.2 Others: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. Middle East & Africa Infusion Devices Market Analysis - by End User

9.1 Hospitals and Specialty Clinics
- 9.1.1 Overview
- 9.1.2 Hospitals and Specialty Clinics: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.2 Homecare Settings
- 9.2.1 Overview
- 9.2.2 Homecare Settings: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.3 Ambulatory Surgical Centers
- 9.3.1 Overview
- 9.3.2 Ambulatory Surgical Centers: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
9.4 Others
- 9.4.1 Overview
- 9.4.2 Others: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)

10. Middle East & Africa Infusion Devices Market - Country Analysis

10.1 Middle East & Africa
- 10.1.1 Middle East & Africa Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.1 Middle East & Africa Infusion Devices Market - Revenue and Forecast Analysis - by Country
  - 10.1.1.2 Saudi Arabia: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.2.1 Saudi Arabia: Middle East & Africa Infusion Devices Market Share - by Product Type
    - 10.1.1.2.2 Saudi Arabia: Middle East & Africa Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.2.3 Saudi Arabia: Middle East & Africa Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.2.4 Saudi Arabia: Middle East & Africa Infusion Devices Market Share - by Application
    - 10.1.1.2.5 Saudi Arabia: Middle East & Africa Infusion Devices Market Share - by End User
  - 10.1.1.3 South Africa: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.3.1 South Africa: Middle East & Africa Infusion Devices Market Share - by Product Type
    - 10.1.1.3.2 South Africa: Middle East & Africa Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.3.3 South Africa: Middle East & Africa Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.3.4 South Africa: Middle East & Africa Infusion Devices Market Share - by Application
    - 10.1.1.3.5 South Africa: Middle East & Africa Infusion Devices Market Share - by End User
  - 10.1.1.4 United Arab Emirates: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.4.1 United Arab Emirates: Middle East & Africa Infusion Devices Market Share - by Product Type
    - 10.1.1.4.2 United Arab Emirates: Middle East & Africa Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.4.3 United Arab Emirates: Middle East & Africa Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.4.4 United Arab Emirates: Middle East & Africa Infusion Devices Market Share - by Application
    - 10.1.1.4.5 United Arab Emirates: Middle East & Africa Infusion Devices Market Share - by End User
  - 10.1.1.5 Rest of Middle East & Africa: Middle East & Africa Infusion Devices Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 10.1.1.5.1 Rest of Middle East & Africa: Middle East & Africa Infusion Devices Market Share - by Product Type
    - 10.1.1.5.2 Rest of Middle East & Africa: Middle East & Africa Infusion Devices Market Share - by Infusion Pumps
    - 10.1.1.5.3 Rest of Middle East & Africa: Middle East & Africa Infusion Devices Market Share - by Infusion Sets
    - 10.1.1.5.4 Rest of Middle East & Africa: Middle East & Africa Infusion Devices Market Share - by Application
    - 10.1.1.5.5 Rest of Middle East & Africa: Middle East & Africa Infusion Devices Market Share - by End User

11. Industry Landscape

11.1 Overview
11.2 Growth Strategies in Infusion Devices Market
11.3 Organic Growth Strategies
- 11.3.1 Overview
11.4 Inorganic Growth Strategies
- 11.4.1 Overview

12. Company Profiles

12.1 Becton Dickinson and Co
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Fresenius Kabi AG
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 B Braun SE
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 CODAN US Corp
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Baxter International Inc
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 Elimedical Inc
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 ICU Medical Inc
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 BPL Medical Technologies Pvt Ltd
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Nipro Corp
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
12.10 KD Scientific Inc
- 12.10.1 Key Facts
- 12.10.2 Business Description
- 12.10.3 Products and Services
- 12.10.4 Financial Overview
- 12.10.5 SWOT Analysis
- 12.10.6 Key Developments
12.11 Medtronic Plc
- 12.11.1 Key Facts
- 12.11.2 Business Description
- 12.11.3 Products and Services
- 12.11.4 Financial Overview
- 12.11.5 SWOT Analysis
- 12.11.6 Key Developments
12.12 Zimed Healthcare Ltd
- 12.12.1 Key Facts
- 12.12.2 Business Description
- 12.12.3 Products and Services
- 12.12.4 Financial Overview
- 12.12.5 SWOT Analysis
- 12.12.6 Key Developments
12.13 Terumo Corp
- 12.13.1 Key Facts
- 12.13.2 Business Description
- 12.13.3 Products and Services
- 12.13.4 Financial Overview
- 12.13.5 SWOT Analysis
- 12.13.6 Key Developments
12.14 Eitan Medical Ltd
- 12.14.1 Key Facts
- 12.14.2 Business Description
- 12.14.3 Products and Services
- 12.14.4 Financial Overview
- 12.14.5 SWOT Analysis
- 12.14.6 Key Developments
12.15 Polymedicure
- 12.15.1 Key Facts
- 12.15.2 Business Description
- 12.15.3 Financial Overview
- 12.15.4 SWOT Analysis
- 12.15.5 Key Developments
12.16 Moog Inc
- 12.16.1 Key Facts
- 12.16.2 Business Description
- 12.16.3 Products and Services
- 12.16.4 Financial Overview
- 12.16.5 SWOT Analysis
- 12.16.6 Key Developments
12.17 Tandem Diabetes Care Inc
- 12.17.1 Key Facts
- 12.17.2 Business Description
- 12.17.3 Products and Services
- 12.17.4 Financial Overview
- 12.17.5 SWOT Analysis
- 12.17.6 Key Developments

13. Appendix

13.1 About The Insight Partners